These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1160 related articles for article (PubMed ID: 9803585)
1. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera. Murray J; McFarland DA; Waldman RJ Bull World Health Organ; 1998; 76(4):343-52. PubMed ID: 9803585 [TBL] [Abstract][Full Text] [Related]
2. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Legros D; Paquet C; Perea W; Marty I; Mugisha NK; Royer H; Neira M; Ivanoff B Bull World Health Organ; 1999; 77(10):837-42. PubMed ID: 10593032 [TBL] [Abstract][Full Text] [Related]
3. Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis. Naficy A; Rao MR; Paquet C; Antona D; Sorkin A; Clemens JD JAMA; 1998 Feb; 279(7):521-5. PubMed ID: 9480362 [TBL] [Abstract][Full Text] [Related]
4. A reassessment of the cost-effectiveness of water and sanitation interventions in programmes for controlling childhood diarrhoea. Varley RC; Tarvid J; Chao DN Bull World Health Organ; 1998; 76(6):617-31. PubMed ID: 10191558 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. Lucas ME; Deen JL; von Seidlein L; Wang XY; Ampuero J; Puri M; Ali M; Ansaruzzaman M; Amos J; Macuamule A; Cavailler P; Guerin PJ; Mahoudeau C; Kahozi-Sangwa P; Chaignat CL; Barreto A; Songane FF; Clemens JD N Engl J Med; 2005 Feb; 352(8):757-67. PubMed ID: 15728808 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of new-generation oral cholera vaccines: a multisite analysis. Jeuland M; Cook J; Poulos C; Clemens J; Whittington D; Value Health; 2009 Sep; 12(6):899-908. PubMed ID: 19824189 [TBL] [Abstract][Full Text] [Related]
9. Oral vaccines for cholera control. Chaturvedi S; Chaturvedi S Natl Med J India; 1997; 10(1):17-8. PubMed ID: 9069701 [TBL] [Abstract][Full Text] [Related]
10. Cost-benefit comparisons of investments in improved water supply and cholera vaccination programs. Jeuland M; Whittington D Vaccine; 2009 May; 27(23):3109-20. PubMed ID: 19428925 [TBL] [Abstract][Full Text] [Related]
11. The value of and challenges for cholera vaccines in Africa. von Seidlein L; Jiddawi M; Grais RF; Luquero F; Lucas M; Deen J J Infect Dis; 2013 Nov; 208 Suppl 1():S8-14. PubMed ID: 24101650 [TBL] [Abstract][Full Text] [Related]
12. Cost-benefit of WC/rBS oral cholera vaccine for vaccination against ETEC-caused travelers' diarrhea. Lundkvist J; Steffen R; Jönsson B J Travel Med; 2009; 16(1):28-34. PubMed ID: 19192125 [TBL] [Abstract][Full Text] [Related]
13. Investigations into the safety and immunogenicity of a killed oral cholera vaccine developed in Viet Nam. Trach DD; Cam PD; Ke NT; Rao MR; Dinh D; Hang PV; Hung NV; Canh DG; Thiem VD; Naficy A; Ivanoff B; Svennerholm AM; Holmgren J; Clemens JD Bull World Health Organ; 2002; 80(1):2-8. PubMed ID: 11884967 [TBL] [Abstract][Full Text] [Related]
14. Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh. Khan IA; Saha A; Chowdhury F; Khan AI; Uddin MJ; Begum YA; Riaz BK; Islam S; Ali M; Luby SP; Clemens JD; Cravioto A; Qadri F Vaccine; 2013 Dec; 31(51):6058-64. PubMed ID: 24161413 [TBL] [Abstract][Full Text] [Related]
15. The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis. Khan AI; Levin A; Chao DL; DeRoeck D; Dimitrov DT; Khan JAM; Islam MS; Ali M; Islam MT; Sarker AR; Clemens JD; Qadri F PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006652. PubMed ID: 30300420 [TBL] [Abstract][Full Text] [Related]
16. Development of Peru-15 (CholeraGarde), a live-attenuated oral cholera vaccine: 1991-2009. Chowdhury MI; Sheikh A; Qadri F Expert Rev Vaccines; 2009 Dec; 8(12):1643-52. PubMed ID: 19943759 [TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of introducing the conjugated pneumococcal vaccine to routine free immunizations for infants in Lazio, Italy. Giorgi-Rossi P; Merito M; Borgia P Health Policy; 2009 Feb; 89(2):225-38. PubMed ID: 18639952 [TBL] [Abstract][Full Text] [Related]
18. Reduction of travellers' diarrhoea by WC/rBS oral cholera vaccine in young, high-risk travellers. Torrell JM; Aumatell CM; Ramos SM; Mestre LG; Salas CM Vaccine; 2009 Jun; 27(30):4074-7. PubMed ID: 19376179 [TBL] [Abstract][Full Text] [Related]
19. Feasibility of a mass vaccination campaign using a two-dose oral cholera vaccine in an urban cholera-endemic setting in Mozambique. Cavailler P; Lucas M; Perroud V; McChesney M; Ampuero S; Guérin PJ; Legros D; Nierle T; Mahoudeau C; Lab B; Kahozi P; Deen JL; von Seidlein L; Wang XY; Puri M; Ali M; Clemens JD; Songane F; Baptista A; Ismael F; Barreto A; Chaignat CL Vaccine; 2006 May; 24(22):4890-5. PubMed ID: 16298025 [TBL] [Abstract][Full Text] [Related]
20. Field trial of a locally produced, killed, oral cholera vaccine in Vietnam. Trach DD; Clemens JD; Ke NT; Thuy HT; Son ND; Canh DG; Hang PV; Rao MR Lancet; 1997 Jan; 349(9047):231-5. PubMed ID: 9014909 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]